Comment

Comment by jjmellon

The problem is that Ivermectin is off patent, so no drug company can make any money from it. Since there is no money for expensive research studies or clinical trials, all the research studies that get done will be low budget and subject to being called "lousy science".

How about just properly reporting and studying the actual facts from one of the very large real world trials, like the one in India?

parent jjmellon 5 years ago

Discussion

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton